OncoCyte Corporation
US ˙ NasdaqCM ˙ US68235C2061
TEN SYMBOL NIE JEST JUŻ AKTYWNY

SecurityOCX / OncoCyte Corporation
InstitutionMorgan Stanley
Latest Disclosed Ownership36,088 shares
Latest Disclosed Value $ 118,369
Morgan Stanley reports 0.49% increase in ownership of OCX / OncoCyte Corporation

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 36,088 shares of OncoCyte Corporation (US:OCX) valued at $118,369 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 35,913 shares of OncoCyte Corporation. This represents a change in shares of 0.49% during the quarter. The current value of the position is $115,482 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 36,088 175 0.49 118 -56.13 0.0000
2026-05-27 2025-12-31 13F/A-1 INSIGHT MOLECULAR DIA COM NEW 68235C206 35,913 -26,295 -42.27 269 30.58 0.0000
2026-02-13 2025-12-31 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 35,913 -26,295 269 0.0000
2026-05-27 2025-09-30 13F/A-1 INSIGHT MOLECULAR DIA COM NEW 68235C206 62,208 0 0.00 207 10.16 0.0000
2025-11-14 2025-09-30 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 62,208 0 207 0.0000
2025-08-15 2025-06-30 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 62,208 500 0.81 188 -0.53 0.0000
2025-05-15 2025-03-31 13F ONCOCYTE COM NEW 68235C206 61,708 0 0.00 189 28.77 0.0000
2025-05-15 2024-12-31 13F/A-1 ONCOCYTE COM NEW 68235C206 61,708 -10,581 -14.64 147 -29.13 0.0000
2025-02-14 2024-12-31 13F ONCOCYTE COM NEW 68235C206 61,708 -10,581 147 0.0000
2025-05-14 2024-09-30 13F/A-2 ONCOCYTE COM NEW 68235C206 72,289 -6,407 -8.14 206 -11.21 0.0000
2025-02-14 2024-09-30 13F/A-1 ONCOCYTE COM NEW 68235C206 72,289 -6,407 206 0.0000
2024-11-14 2024-09-30 13F ONCOCYTE COM NEW 68235C206 72,289 -6,407 206 0.0000
2025-05-14 2024-06-30 13F/A-2 ONCOCYTE COM NEW 68235C206 78,696 -44,515 -36.13 232 -35.73 0.0000
2024-10-17 2024-06-30 13F/A-1 ONCOCYTE COM NEW 68235C206 78,696 -44,515 232 0.0000
2024-08-14 2024-06-30 13F ONCOCYTE COM NEW 68235C206 78,696 -44,515 232 0.0000
2024-10-17 2024-03-31 13F/A-2 ONCOCYTE COM NEW 68235C206 123,211 238 0.19 361 17.59 0.0000
2024-08-16 2024-03-31 13F/A-1 ONCOCYTE COM NEW 68235C206 123,211 238 361 0.0000
2024-05-15 2024-03-31 13F ONCOCYTE COM NEW 68235C206 123,211 238 361 0.0000
2024-08-16 2023-12-31 13F/A-1 ONCOCYTE COM NEW 68235C206 122,973 -16,565 -11.87 307 -29.43 0.0000
2024-02-13 2023-12-31 13F ONCOCYTE COM NEW 68235C206 122,973 -16,565 307 0.0000
2023-11-15 2023-09-30 13F ONCOCYTE COM NEW 68235C206 139,538 139,538 435 0.0000
2023-08-14 2023-06-30 13F ONCOCYTE COM 68235C107 2,790,933 2,754,399 7,539.28 642 5,241.67 0.0001
2023-05-15 2023-03-31 13F ONCOCYTE COM 68235C107 36,534 -7,510 -17.05 13 -14.29 0.0000
2023-02-14 2022-12-31 13F ONCOCYTE COM 68235C107 44,044 -65,299 -59.72 14 -82.50 0.0000
2022-11-14 2022-09-30 13F ONCOCYTE COM 68235C107 109,343 -39,099 -26.34 80 -40.30 0.0000
2022-10-27 2022-06-30 13F/A-1 ONCOCYTE COM 68235C107 148,442 -47,723 -24.33 134 -54.11 0.0000
2022-08-15 2022-06-30 13F ONCOCYTE COM 68235C107 148,442 -47,723 134 0.0000
2022-10-27 2022-03-31 13F/A-1 ONCOCYTE COM 68235C107 196,165 -50,004 -20.31 292 -45.32 0.0000
2022-05-13 2022-03-31 13F ONCOCYTE COM 68235C107 196,165 -50,004 292 0.0000
2022-02-14 2021-12-31 13F ONCOCYTE COM 68235C107 246,169 161,931 192.23 534 78.00 0.0001
2021-11-15 2021-09-30 13F ONCOCYTE COM 68235C107 84,238 5,268 6.67 300 -33.77 0.0000
2021-08-23 2021-06-30 13F/A-1 ONCOCYTE COM 68235C107 78,970 2,635 3.45 453 14.39 0.0001
2021-08-16 2021-06-30 13F ONCOCYTE COM 68235C107 78,970 2,635 453 0.0000
2021-05-17 2021-03-31 13F ONCOCYTE COM 68235C107 76,335 -9,773 -11.35 396 93.17 0.0001
2021-02-16 2020-12-31 13F ONCOCYTE COM 68235C107 86,108 45,824 113.75 205 266.07 0.0000
2020-11-13 2020-09-30 13F ONCOCYTE COM 68235C107 40,284 -9,860 -19.66 56 -41.67 0.0000
2020-08-14 2020-06-30 13F ONCOCYTE COM 68235C107 50,144 14,393 40.26 96 10.34 0.0000
2020-05-26 2020-03-31 13F/A-1 ONCOCYTE COM 68235C107 35,751 -29,228 -44.98 87 -40.41 0.0000
2020-05-15 2020-03-31 13F ONCOCYTE COM 68235C107 35,751 -29,228 87 6.6834
2020-02-14 2019-12-31 13F ONCOCYTE COM 68235C107 64,979 22,963 54.65 146 65.91 0.0000
2019-11-14 2019-09-30 13F ONCOCYTE COM 68235C107 42,016 9,637 29.76 88 8.64 0.0000
2019-08-14 2019-06-30 13F ONCOCYTE COM 68235C107 32,379 -9,793 -23.22 81 -51.50 0.0000
2019-05-15 2019-03-31 13F ONCOCYTE COM 68235C107 42,172 12,735 43.26 167 307.32 0.0000
2019-02-14 2018-12-31 13F ONCOCYTE COM 68235C107 29,437 215 0.74 41 -43.84 0.0000
2019-04-23 2018-09-30 13F/A-2 ONCOCYTE COM 68235C107 29,222 18,539 173.54 73 160.71 0.0000
2018-11-20 2018-09-30 13F/A-1 ONCOCYTE COM 68235C107 29,222 19,538 73 0.0000
2018-11-14 2018-09-30 13F ONCOCYTE COM 68235C107 29,222 18,539 73
2019-04-23 2018-06-30 13F/A-1 ONCOCYTE COM 68235C107 10,683 -5,399 -33.57 28 -17.65 0.0000
2018-08-14 2018-06-30 13F ONCOCYTE COM 68235C107 10,683 -5,399 28
2019-04-23 2018-03-31 13F/A-1 ONCOCYTE COM 68235C107 16,082 41 0.26 34 -54.67 0.0000
2018-05-14 2018-03-31 13F ONCOCYTE COM 68235C107 16,082 41 34
2019-04-23 2017-12-31 13F/A-1 ONCOCYTE COM 68235C107 16,041 6,178 62.64 75 0.00 0.0000
2018-02-14 2017-12-31 13F ONCOCYTE COM 68235C107 16,041 6,178 75
2017-11-14 2017-09-30 13F ONCOCYTE COM 68235C107 9,863 3,706 60.19 75 134.38 0.0000
2017-08-11 2017-06-30 13F ONCOCYTE COM 68235C107 6,157 2,931 90.86 32 68.42 0.0000
2017-05-22 2017-03-31 13F/A-1 ONCOCYTE COM 68235C107 3,226 2,080 181.50 19 137.50 0.0000
2017-05-12 2017-03-31 13F ONCOCYTE COM 68235C107 3,226 19
2017-02-22 2016-12-31 13F/A-1 ONCOCYTE COM 68235C107 1,146 1,106 2,765.00 8 0.0000
2017-02-13 2016-12-31 13F ONCOCYTE COM 68235C107 1,146 8
2016-11-10 2016-09-30 13F ONCOCYTE COM 68235C107 40 -930 -95.88 0 -100.00
2016-08-12 2016-06-30 13F ONCOCYTE COM 68235C107 970 467 92.84 3 50.00 0.0000
2016-05-12 2016-03-31 13F ONCOCYTE COM 68235C107 503 503 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.